Population pharmacokinetics of rituximab in patients with diffuse large B‐cell lymphoma and association with clinical outcome

AIMS: Pharmacokinetic (PK) studies suggest that there is a room for improvement in clinical use of rituximab through more individualized treatment. The objective of this study was to characterize rituximab PK in 29 newly diagnosed patients with diffuse large B‐cell lymphoma treated with rituximab in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Clin Pharmacol
Prif Awduron: Rozman, Samo, Grabnar, Iztok, Novaković, Srdjan, Mrhar, Ales, Jezeršek Novaković, Barbara
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Pharmacokinetic Dynamic Relationships
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510082/
https://ncbi.nlm.nih.gov/pubmed/28239897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13271
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg